K&L Gates LLP represented the underwriters in connection with the $220 million initial public offering of Forward Pharma A/S, a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis and other immune disorders such as psoriasis. Forward Pharma issued 10.5 million American Depositary Shares (ADSs), representing the company’s ordinary shares at a price to the public of $21 per ADS. The ADSs now trade on the NASDAQ Global Select Market under the ticker symbol “FWP”.

Clifford Chance has advised the underwriting banks led by Kempen & Co on the successful IPO of Probiodrug AG.  Probiodrug AG with its registered office in Halle, Germany, is a biopharmaceutical company dedicated to the research and development of novel therapeutic solutions to treat people with Alzheimer's disease.

Hill Dickinson's corporate team has advised Zeus Capital as nominated adviser and broker on the AIM IPO of C4X Discovery Holdings plc (C4X). The AIM IPO included a £11 million fundraise to provide new capital for C4X. On admission, C4X had a market capitalisation of £31 million.

Davis Polk advised Ouro Fino Saude Animal Participacoes S.A. and the selling shareholders, in connection with the initial public offering by Ouro Fino and the selling shareholders of 13,461,539 common shares for an aggregate amount of R$363 million. The common shares trade on the Sao Paulo Stock Exchange. Common shares sold in the international offering were placed under Rule 144A and Regulation S. This was the only IPO in Brazil to date in 2014.  

Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated as representative of the initial purchasers in connection with a Rule 144A offering by Monster Worldwide, Inc. of an aggregate principal amount of $143.75 million of 3.5% convertible senior notes due 2019, which included $18.75 million aggregate principal amount of convertible senior notes issued pursuant to the exercise in full of the initial purchasers’ over-allotment option. 

Noerr advised CLIQ Digital AG on two combined capital measures, firstly, a rights offering regarding new shares from a capital increase against cash contribution and secondly, the issuance of a convertible bond with subscription rights of the shareholders. The new shares and the convertible bond will be offered to the public in Germany and Luxembourg. The Noerr team was led by partners Dr. Stephan Schulz and Dr. Holger Alfes.

Shearman and Sterling represented Morgan Stanley & Co. LLC, Barclays Capital Inc., Goldman, Sachs & Co., RBC Capital Markets, LLC, Citigroup Global Markets Inc., SunTrust Robinson Humphrey, Inc., Cowen and Company, LLC, Oppenheimer & Co.

Freshfields Bruckhaus Deringer has advised a consortium of underwriters on a rights issue and related finance facilities from Country Garden Holdings Company Limited. Country Garden is a Hong Kong listed company and one of the leading real estate developers in mainland China.

The rights issue, consisting of 1,271,988,736 shares at HK$2.50 each, closed on 13 October 2014 at an aggregate value of approximately US$408m.

Allen & Overy LLP is advising Perry Capital on the successful placement of 2,365,940 shares of LEG Immobilien AG raising funds of around EUR 118 million.

The shares were sold to institutional investors by way of private placement in an accelerated book building.

Parallel to this placement, LEG Immobilien AG has utilised some of its authorised capital and increased its share capital. The new shares were also sold to institutional investors by way of private placement.

Legal Advisors, Abdulaziz I. Al-Ajlan & Partners In Association with Baker & McKenzie has advised the financial advisors and lead managers on the initial public offering (IPO) of The National Commercial Bank, Saudi Arabia's largest lender.

The deal, raising SAR22.5 billion (USD6 billion), is the second-largest IPO in the world this year and the largest-ever equity sale in the Middle East, surpassing the USD5 billion raised by Dubai’s DP World in 2007.